Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home Companies111 Inc

111 Inc

Healthcare Medical Distribution
PortfolioPortfolio WatchlistWatchlist
Company price
2.95 USD 0.02 ( 0.72%)
Last update at 2026-11-10T14:34:00Z
VOLUME
343
Market Cap
108.79M

Momentum Score

…

111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates in two segments, B2C and B2B. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices comprising bandages and thermometers; and personal care products consisting of skin care, birth control, sexual wellness products, and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Pharmacy, which include pharmacies and wholesalers; and data and supply chain integration services. In addition, it offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. The company operates offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangdong, Guangzhou, Tianjin, and Kunshan. It serves pharmacies, pharmaceutical companies, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
2.95
Low
2.95
High
52 Week Price Range
0.97
Low
3.36
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

111 Inc operates an online healthcare platform in China that retails prescription and over‑the‑counter medicines, health products and related distribution and digital services. Long-term growth drivers include China's aging population, rising adoption of online pharmacies and greater digitalization of healthcare, which may benefit platform volume and logistics scale; the company appears positioned to capture part of the channel shift to e-commerce through its retail and distribution capabilities.

Key investment risks include regulatory changes affecting online drug sales and healthcare policy, intense competition from larger technology and pharmacy players, margin pressure and execution risk in maintaining compliant supply chains and profitability.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
2.93
Dividend Yield
-
Revenue TTM
14779.80M
Revenue Per Share
174.31
Gross Profit TTM
265.26M
Debt / Equity
-0.76
ROE
-72.35%
Net Debt
-160.29M
ROCE
-107.86%
Diluted EPS TTM
-0.66

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -376.07M -621.02M -467.11M -501.83M -382.03M
Minority interest -40.81M -48.78M 973.24M -2.73M -0.51M
Net income -408.50M -662.97M -459.04M -492.39M -380.09M
Selling general administrative 746.54M 752.10M 447.24M 314.40M 243.94M
Selling and marketing expenses 457.88M 513.15M 399.61M 340.56M 260.04M
Gross profit 839.98M 621.10M 365.83M 165.18M 104.27M
Reconciled depreciation 40.82M 27.22M - 11.67M 11.27M
Ebit -371.00M -642.14M -473.31M -493.51M -395.76M
Ebitda -354.75M -617.47M -463.84M -487.88M -384.49M
Depreciation and amortization 16.25M 24.67M 9.47M 5.64M 11.27M
Non operating income net other - - - 0.00M 0.00M
Operating income -371.00M -642.14M -473.31M -493.51M -400.38M
Other operating expenses 13887.70M 13068.04M 8676.47M 4445.57M 2186.34M
Interest expense 13.44M 5.49M 8.82M 3.62M 0.00M
Tax provision 0.00M 0.00M 0.00M 0.00M 0.01M
Interest income 8.12M 9.78M 6.31M 4.80M 4.35M
Net interest income -5.33M 4.29M -2.50M 1.18M 4.35M
Extraordinary items - - - 0.00M 0.00M
Non recurring - - - 0.00M 0.00M
Other items - - - 0.00M 0.00M
Income tax expense 32.43M 41.94M -8.07M -9.43M 0.01M
Total revenue 13516.70M 12425.90M 8203.16M 3952.05M 1785.97M
Total operating expenses 1210.98M 1263.23M 839.14M 658.70M 504.64M
Cost of revenue 12676.72M 11804.81M 7837.32M 3786.87M 1681.70M
Total other income expense net -5.07M 21.11M 6.20M -8.31M 13.99M
Discontinued operations - - - 0.00M 0.00M
Net income from continuing ops -376.07M -621.02M -467.11M -501.83M -382.04M
Net income applicable to common shares - -669.81M -456.53M -499.61M -380.09M
Preferred stock and other adjustments - - - 0.00M 0.00M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 3089.04M 3473.81M 3145.83M 3026.49M 1610.29M
Intangible assets 2.26M 3.27M 4.91M 0.92M 8.02M
Other current assets 9.40M 282.07M 5.96M 4.12M 6.99M
Total liab 2812.93M 2825.58M 2297.13M 1695.84M 836.37M
Total stockholder equity -583.45M -414.60M -173.32M 357.40M 776.66M
Deferred long term liab - - - - 0.00M
Other current liab 622.27M 457.70M 273.50M 196.10M 159.24M
Common stock 0.06M 0.06M 0.06M 0.06M 0.06M
Capital stock 0.06M 0.06M 0.06M 0.06M 0.06M
Retained earnings -3819.25M -3426.56M -3009.68M -2339.87M -1883.34M
Other liab - - 1.54M 3.74M 5.94M
Good will - - - 5.60M 0.00M
Other assets - - 22.09M 5.06M 3.01M
Cash 603.52M 673.67M 661.39M 1189.62M 613.75M
Total current liabilities 2745.06M 2725.11M 2129.98M 1629.72M 745.63M
Current deferred revenue 153.50M 323.57M 202.56M 131.01M 74.77M
Net debt -160.29M -394.21M -236.12M -897.98M -461.65M
Short term debt 380.61M 178.99M 259.66M 229.25M 95.08M
Short long term debt 338.07M 178.99M 259.66M 229.25M 95.08M
Short long term debt total 443.23M 279.46M 425.27M 291.64M 152.09M
Other stockholder equity 3163.23M 2936.32M 2776.93M 2634.31M 2583.49M
Property plant equipment - - 314.10M 142.07M 117.69M
Total current assets 2933.33M 3235.82M 2801.74M 2872.70M 1481.43M
Long term investments 2.00M 2.00M 3.00M 0.14M 0.14M
Net tangible assets - - -178.23M 350.89M 768.63M
Short term investments 50.14M 205.86M 182.56M 300.17M 0.00M
Net receivables 776.51M 532.21M 495.20M 175.68M 88.83M
Long term debt - - - - 0.00M
Inventory 1419.40M 1498.90M 1121.11M 766.53M 486.27M
Accounts payable 1588.69M 1764.85M 1394.25M 1073.35M 416.54M
Total permanent equity - - - - 0.00M
Noncontrolling interest in consolidated entity - - - - 0.00M
Temporary equity redeemable noncontrolling interests - - - - 0.00M
Accumulated other comprehensive income 72.51M 75.59M 59.37M 62.91M 76.44M
Additional paid in capital - - - - 0.00M
Common stock total equity - - - 0.06M 0.06M
Preferred stock total equity - - - - 0.00M
Retained earnings total equity - - - - 0.00M
Treasury stock - - - - -22.99M
Accumulated amortization - - - - 0.00M
Non currrent assets other 13.31M 20.35M 22.09M 5.06M 3.01M
Deferred long term asset charges - - - - 0.00M
Non current assets total 155.71M 237.99M 344.10M 153.78M 128.86M
Capital lease obligations 105.15M 100.47M 165.61M 62.39M 88.11M
Long term debt total - - - - 0.00M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -47.17M 60.14M -324.67M 262.11M 44.45M
Change to liabilities - 274.00M 629.02M 232.08M 84.12M
Total cashflows from investing activities - 60.14M -324.67M 237.68M 44.45M
Net borrowings - 30.41M 134.17M 95.08M 95.08M
Total cash from financing activities 22.73M 27.44M 1070.41M 106.95M 972.70M
Change to operating activities - -0.92M -22.17M -23.22M -23.01M
Net income -376.07M -621.02M -456.53M -501.83M -382.04M
Change in cash -43.88M -557.86M 620.81M -156.02M 686.08M
Begin period cash flow 760.67M 1318.53M 697.72M 853.74M 167.66M
End period cash flow 716.79M 760.67M 1318.53M 697.72M 853.74M
Total cash from operating activities -23.15M -641.94M -116.78M -510.19M -343.02M
Issuance of capital stock 0.27M 2.92M 6.33M 11.33M 972.70M
Depreciation 40.82M 27.22M 14.02M 11.67M 11.27M
Other cashflows from investing activities - 60.14M -324.67M -324.67M -324.67M
Dividends paid - -359.94M - -148.88M 0.00M
Change to inventory 28.50M -400.55M 24.22M -276.23M -66.78M
Change to account receivables -86.98M -242.40M -98.28M -36.68M -8.17M
Sale purchase of stock 0.00M -5.89M -11.98M -22.99M 972.70M
Other cashflows from financing activities 891.28M 766.77M 1076.06M 323.32M 277.82M
Change to netincome - 27.87M 339.76M 79.60M 39.65M
Capital expenditures 31.57M 62.69M 25.50M 24.61M 14.82M
Change receivables - - - 0.00M 0.00M
Cash flows other operating - - - 0.00M 0.00M
Exchange rate changes - - - 0.00M 0.00M
Cash and cash equivalents changes - - - 0.00M 0.00M
Change in working capital 359.02M -369.87M 4.97M -103.26M -13.84M
Stock based compensation 162.07M 145.59M 75.69M 54.28M 51.36M
Other non cash items -208.99M 89.78M 334.79M 25.39M -11.71M
Free cash flow -54.73M -704.63M -142.28M -534.80M -357.84M

Peer Comparison*

Sector: Healthcare Industry: Medical Distribution

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
YI
111 Inc		 0.02
0.72%		 2.95 - - 0.01 -0.69 0.00 -0.13
MCK
McKesson Corporation		 4.53
0.43%		 1063.90 24.45 20.41 0.26 5.04 0.27 15.03
COR
Cencora Inc.		 -2.51
0.73%		 343.25 24.22 16.39 0.19 20.41 0.21 13.72
CAH
Cardinal Health Inc		 -0.93
0.34%		 273.36 29.48 17.92 0.20 16.07 0.22 15.67
HSIC
Henry Schein Inc		 0.05
0.06%		 88.46 25.89 15.08 0.72 3.14 1.00 13.43

Profile*

111 Inc

111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates in two segments, B2C and B2B. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices comprising bandages and thermometers; and personal care products consisting of skin care, birth control, sexual wellness products, and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Pharmacy, which include pharmacies and wholesalers; and data and supply chain integration services. In addition, it offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. The company operates offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangdong, Guangzhou, Tianjin, and Kunshan. It serves pharmacies, pharmaceutical companies, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.

No.295 ZuChongZhi Road, Shanghai, China, 201203

86 21 2053 6666

https://corporate.111.com.cn

Name Title Year Born
Dr. Gang Yu Co-Founder & Exec. Chairman 1959
Mr. Junling Liu Co-Founder, Acting CFO, Chairman & CEO 1965
Mr. Haihui Wang Co-Chief Operating Officer NA
Mr. Pengcheng Zhu Co-Chief Operating Officer NA
Monica Mu IR Director NA
Mr. Anfeng Guo Chief Innovation Officer NA
Mr. Yang Chen CFO at Yaofang Information Technology (Shanghai) Co., Ltd. 1971
Mr. Alex Liu Fin. Director NA
Dr. Gang Yu Co-Founder & Executive Chairman 1959
Mr. Alex Liu Finance Director NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

QTWO
CAD 1.78
+10.56%
NEO
CAD 27.77
+5.91%
CGI
CAD 52.81
+4.78%
PET
CAD 22.34
+3.81%
QBR-A
CAD 77.96
+2.40%
GFL
CAD 57.98
-10.54%
MUX
CAD 21.12
-7.53%
BYN
CAD 1.58
-7.06%
BRVO
CAD 2.23
-6.89%
ITR
CAD 3.12
-6.87%

Equity Sectors*

  • Basic Materials

    -2.54%

  • Communication Services

    +0.09%

  • Consumer Cyclical

    -0.16%

  • Consumer Defensive

    -0.14%

  • Energy

    -1.11%

  • Financial Services

    +0.15%

  • Healthcare

    -0.77%

  • Industrials

    -0.93%

  • Real Estate

    -0.17%

  • Technology

    -0.09%

  • Utilities

    -0.67%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…